|
WO2004062664A1
(en)
*
|
2002-12-30 |
2004-07-29 |
Vertex Pharmaceuticals Incorporated |
Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
|
|
WO2005035551A2
(en)
|
2003-10-08 |
2005-04-21 |
Incyte Corporation |
Inhibitors of proteins that bind phosphorylated molecules
|
|
CN101321743A
(en)
*
|
2005-12-08 |
2008-12-10 |
诺瓦提斯公司 |
L , l , 3-tri0x0-l , 2 , 5-thiadiaz0lidines and their use as PTP-ases inhibitors
|
|
UA94724C2
(en)
*
|
2005-12-08 |
2011-06-10 |
Новартис Аг |
Thiadiazolidinone derivatives as antidiabetic agents
|
|
UA94921C2
(en)
*
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
|
ES2397177T3
(en)
*
|
2005-12-08 |
2013-03-05 |
Novartis Ag |
1,2,5-Thiazolidine derivatives useful for the treatment of conditions mediated by protein tyrosine phosphatases (PTPASA)
|
|
EP2038267A2
(en)
|
2006-03-31 |
2009-03-25 |
Novartis AG |
Thiadiazolidinone inhibitors of ptpase
|
|
RU2009108280A
(en)
|
2006-08-08 |
2010-09-20 |
Санофи-Авентис (Fr) |
Arylamino-arylalkyl-substituted imidazolidine-2,4-dione, methods for their preparation containing these compounds and their use
|
|
WO2008067527A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Novartis Ag |
Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders
|
|
AR066820A1
(en)
*
|
2007-06-04 |
2009-09-16 |
Novartis Ag |
TIADIAZOLIDIN-3 ONA COMPOUNDS
|
|
EP2025674A1
(en)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
WO2011023754A1
(en)
|
2009-08-26 |
2011-03-03 |
Sanofi-Aventis |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
|
WO2011106273A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
EA025380B1
(en)
|
2011-02-25 |
2016-12-30 |
Мерк Шарп Энд Домэ Корп. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
WO2012120054A1
(en)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683699B1
(en)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
US8901114B2
(en)
|
2011-03-08 |
2014-12-02 |
Sanofi |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
|
|
EP2683704B1
(en)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683701B1
(en)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use
|
|
WO2012120051A1
(en)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
EP2683702B1
(en)
|
2011-03-08 |
2014-12-24 |
Sanofi |
New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
KR102100093B1
(en)
|
2012-07-31 |
2020-05-15 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
Methods and compositions for in vivo induction of pancreatic beta cell formation
|
|
KR20150036245A
(en)
|
2012-08-02 |
2015-04-07 |
머크 샤프 앤드 돔 코포레이션 |
Antidiabetic tricyclic compounds
|
|
RU2015140066A
(en)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
ANTI-DIABETIC BICYCLIC COMPOUNDS
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
JP6318467B2
(en)
*
|
2013-04-18 |
2018-05-09 |
Jsr株式会社 |
Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, retardation film, retardation film production method and polymer
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
US10968232B2
(en)
|
2016-12-20 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|